Dapsona (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dapsona" in Spanish language version.

refsWebsite

Global rank Spanish rank

18nih.gov

4^th place

7doi.org

2^nd place

2web.archive.org

1^st place

2who.int

195^th place

173^rd place

1drugs.com

399^th place

648^th place

1issn.org

57^th place

3^rd place

1ijpcsonline.com

low place

1unmsm.edu.pe

6,272^nd place

515^th place

1dcmq.com.mx

low place

1nejm.org

2,374^th place

1,798^th place

1paho.org

8,358^th place

1,264^th place

1pharmacistanswers.com

low place

1amh.net.au

low place

amh.net.au

Rossi S, ed. (2011 Jan). «Australian Medicines Handbook 2011».

dcmq.com.mx

Miller, MC; Coutiño, GM (enero-marzo 2014). «Dapsona: su uso en dermatología». Dermatología Cosmética, Médica y Quirúrgica 12 (1): 47-51.

doi.org

dx.doi.org

Zhu, YI; Stiller, MJ (2001 Sep). «Dapsone and sulfones in dermatology: overview and update». J Am Acad Dermatol 45 (3): 420-34. PMID 11511841. doi:10.1067/mjd.2001.114733.
Wozel, VE (2010 Jul). «Innovative use of dapsone». Dermatol Clin 28 (3): 599-610. PMID 20510768. doi:10.1016/j.det.2010.03.014.
Zhang, FR; Liu, H; Irwanto, A; Fu, XA; Li, Y; Yu, GQ; Yu, YX; et al. (2013 Oct 24). «HLA-B*13:01 and the dapsone hypersensitivity syndrome». N Engl J Med 369 (17): 1620-8. PMID 24152261. doi:10.1056/NEJMoa1213096.
Luzzatto, L (2010 Aug 28). «The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics». Lancet 376 (9742): 739-41. PMID 20599264. doi:10.1016/S0140-6736(10)60396-0.
Lorenz, M; Wozel, G; Schmitt, J (2012 Mar). «Hypersensitivity reactions to dapsone: a systematic review». Acta Derm Venereol 92 (2): 194-9. PMID 22307940. doi:10.2340/00015555-1268.
Ganesan, S; Sahu, R; Walker, LA; Tekwani, BL (2010 Apr). «Cytochrome P450-dependent toxicity of dapsone in human erythrocytes». J Appl Toxicol 30 (3): 271-5. PMID 19998329. doi:10.1002/jat.1493.
Poschenrieder, F; Schulz, C; Hamer, OW (2014 Feb). «Eosinophilic pneumonia toxicity induced by Dapsone». Rofo 186 (2): 178-9. PMID 23996619. doi:10.1055/s-0033-1350517.

drugs.com

«Dapsone (Systemic) Monograph for Professionals». The American Society of Health-System Pharmacists. Consultado el 12-1-2015.

ijpcsonline.com

Mane, PB; Antre, RV; Oswal, RJ (2012 Apr – Jun). «Antileprotic Drugs: An Overview». International Journal of Pharmaceutcial and Chemical Scienses 1 (2). ISSN 2277-5005. Archivado desde el original el 29 de noviembre de 2014. Consultado el 26 de noviembre de 2014.

issn.org

portal.issn.org

Mane, PB; Antre, RV; Oswal, RJ (2012 Apr – Jun). «Antileprotic Drugs: An Overview». International Journal of Pharmaceutcial and Chemical Scienses 1 (2). ISSN 2277-5005. Archivado desde el original el 29 de noviembre de 2014. Consultado el 26 de noviembre de 2014.

nejm.org

Zhang, FR; Liu, H; Irwanto, A; Fu, XA; Li, Y; Yu, GQ; Yu, YX; et al. (2013 Oct 24). «HLA-B*13:01 and the dapsone hypersensitivity syndrome». N Engl J Med 369 (17): 1620-8. PMID 24152261. doi:10.1056/NEJMoa1213096.

nih.gov

ncbi.nlm.nih.gov

Zhu, YI; Stiller, MJ (2001 Sep). «Dapsone and sulfones in dermatology: overview and update». J Am Acad Dermatol 45 (3): 420-34. PMID 11511841. doi:10.1067/mjd.2001.114733.
Wozel, VE (2010 Jul). «Innovative use of dapsone». Dermatol Clin 28 (3): 599-610. PMID 20510768. doi:10.1016/j.det.2010.03.014.
Zhang, FR; Liu, H; Irwanto, A; Fu, XA; Li, Y; Yu, GQ; Yu, YX; et al. (2013 Oct 24). «HLA-B*13:01 and the dapsone hypersensitivity syndrome». N Engl J Med 369 (17): 1620-8. PMID 24152261. doi:10.1056/NEJMoa1213096.
Jopling, WH (1983 Dec). «Side-effects of antileprosy drugs in common use». Lepr Rev 54 (4): 261-70. PMID 6199637.
Jollow, DJ; Bradshaw, TP; McMillan, DC (1995). «Dapsone-induced hemolytic anemia». Drug Metab Rev 27 (1-2): 107-24. PMID 7641572.
Puavilai, S; Chutha, S; Polnikorn, N; Timpatanapong, P; Tasanapradit, P; Charuwichitratana, S; Boonthanom, A; et al. (1984 Jul). «Incidence of anemia in leprosy patients treated with dapsone». J Med Assoc Thai 67 (7): 404-7. PMID 6512448.
Luzzatto, L (2010 Aug 28). «The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics». Lancet 376 (9742): 739-41. PMID 20599264. doi:10.1016/S0140-6736(10)60396-0.
Sanders, SW; Zone, JJ; Foltz, RL; Tolman, KG; Rollins, DE (1982 Apr). «Hemolytic anemia induced by dapsone transmitted through breast milk». Ann Intern Med 96 (4): 465-6. PMID 7065565.
Coleman, MD (2001 Apr 12). «Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention». Toxicology 162 (1): 53-60. PMID 11311458.
Foucauld, J; Uphouse, W; Berenberg, J (1985 Jan). «Dapsone and aplastic anemia». Ann Intern Med 102 (1): 139. PMID 3966740.
Björkman, A; Phillips-Howard, PA (1991). «Adverse reactions to sulfa drugs: implications for malaria chemotherapy». Bull World Health Organ 69 (3): 297-304. PMID 1893504.
Lorenz, M; Wozel, G; Schmitt, J (2012 Mar). «Hypersensitivity reactions to dapsone: a systematic review». Acta Derm Venereol 92 (2): 194-9. PMID 22307940. doi:10.2340/00015555-1268.
Ganesan, S; Sahu, R; Walker, LA; Tekwani, BL (2010 Apr). «Cytochrome P450-dependent toxicity of dapsone in human erythrocytes». J Appl Toxicol 30 (3): 271-5. PMID 19998329. doi:10.1002/jat.1493.
Poschenrieder, F; Schulz, C; Hamer, OW (2014 Feb). «Eosinophilic pneumonia toxicity induced by Dapsone». Rofo 186 (2): 178-9. PMID 23996619. doi:10.1055/s-0033-1350517.
Richardus, JH; Smith, TC (1989 Dec). «Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy». Lepr Rev 60 (4): 267-73. PMID 2491425.
Kumar, RH; Kumar, MV; Thappa, DM (1998 Jul-Sep). «Dapsone syndrome--a five year retrospective analysis». Indian J Lepr 70 (3): 271-6. PMID 9801899.
Rao, PN; Lakshmi, TS (2001 Mar). «Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal». Lepr Rev 72 (1): 57-62. PMID 11355519.
Kromann, NP; Vilhelmsen, R; Stahl, D (1982 Jul). «The dapsone syndrome». Arch Dermatol 118 (7): 531-2. PMID 7092282.

paho.org

new.paho.org

Boletín de medicamentos y salud para las Américas 1 (2). Agosto de 2008.

pharmacistanswers.com

url= http://www.pharmacistanswers.com/medications-for-acne-guide.html Archivado el 4 de marzo de 2016 en Wayback Machine.

unmsm.edu.pe

sisbib.unmsm.edu.pe

Sánchez- Saldaña, L (2008). «Medicamentos antiguos y vigentes en dermatología». Dermatología Peruana 18 (3): 249-58.

web.archive.org

Mane, PB; Antre, RV; Oswal, RJ (2012 Apr – Jun). «Antileprotic Drugs: An Overview». International Journal of Pharmaceutcial and Chemical Scienses 1 (2). ISSN 2277-5005. Archivado desde el original el 29 de noviembre de 2014. Consultado el 26 de noviembre de 2014.
url= http://www.pharmacistanswers.com/medications-for-acne-guide.html Archivado el 4 de marzo de 2016 en Wayback Machine.

who.int

apps.who.int

«WHO Model List of EssentialMedicines». World Health Organization. 2013 October.

who.int

World Health Organization (4 de marzo de 2008). Information Exchange System Alert No. 117 - Antimalarial chlorproguanil-dapsone (LapDap^™) withdrawn following demonstration of post-treatment haemolytic anaemia in G6PD deficient patients in a Phase III trial of chlorproguanil-dapsone-artesunate (Dacart^™) versus artemether-lumefantrine (Coartem^®) and confirmation of findings in a comparative trial of LapDap^™ versus Dacart ^™.